Shopping Cart
Remove All
Your shopping cart is currently empty
KWAR23 is a monoclonal antibody targeting SIRPα that blocks the interaction of SIRPα and SIRPγ with CD47, impairing chronic T-cell activation and IFN-γ secretion.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $447 | - | In Stock | |
| 5 mg | $1,400 | - | In Stock | |
| 10 mg | $2,100 | - | In Stock | |
| 25 mg | $4,210 | - | In Stock |
| Description | KWAR23 is a monoclonal antibody targeting SIRPα that blocks the interaction of SIRPα and SIRPγ with CD47, impairing chronic T-cell activation and IFN-γ secretion. |
| In vitro | The EC50 binding of KWAR23 to SIRPα on human CD14+ monocytes ranged from 0.267 to 0.385 μg/mL. In non-human primates, such as cynomolgus monkeys and rhesus monkeys, KWAR23 binds to CD14+ mononuclear cells with SIRP alpha and EC50 of 0.338 and 0.4, respectively. KWAR23 blocked the binding of CD47 to THP-1 cells, IC50 = 40.82 ng/mL. [1] |
| In vivo | KWAR23 showed potent antitumor activity in human SIRPA knock-in mouse models. [1] |
| Synonyms | KWAR 23 |
| Molecular Weight | 145.5 |
| Smiles | #N/A |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.